Evidence map›Paper›PMID 38133999›Full record

ArticlePLOS global public health2023

Adolescents and young adults are the most undiagnosed of HIV and virally unsuppressed in Eastern and Southern Africa: Pooled analyses from five population-based surveys.

Helena Huerga, Jihane Ben Farhat, David Maman, Nolwenn Conan, Gilles Van Cutsem, Willis Omwoyo, Daniela Garone, Reinaldo Ortuno Gutierrez, Tsitsi Apollo, Gordon Okomo and 1 more

Abstract read
In one paragraph

Article in PLOS global public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Helena HuergaDepartment of Field Epidemiology, Epicentre, Paris, France.ORCID https://orcid.org/0000-0003-0302-9063
Jihane Ben FarhatDepartment of Field Epidemiology, Epicentre, Paris, France.ORCID https://orcid.org/0000-0002-6362-1264
David MamanDepartment of Field Epidemiology, Epicentre, Paris, France.
Nolwenn ConanDepartment of Field Epidemiology, Epicentre, Paris, France.ORCID https://orcid.org/0000-0002-7182-4934
Gilles Van CutsemSouthern Africa Medical Unit, Médecins Sans Frontières, Cape Town, South Africa.ORCID https://orcid.org/0000-0002-8972-4480
Willis OmwoyoAIDS & STI Department, Ministry of Health, Homa Bay, Kenya.
Daniela GaroneDepartment of Medicine, Médecins Sans Frontières, Harare, Zimbabwe.
Reinaldo Ortuno GutierrezDepartment of Medicine, Médecins Sans Frontières, Nsanje, Malawi.
Tsitsi ApolloDepartment of HIV/STIs, Ministry of Health and Child Care, Harare, Zimbabwe.
Gordon OkomoDepartment of Medicine, Ministry of Health, Homa Bay, Kenya.
Jean-François EtardDepartment of Field Epidemiology, Epicentre, Paris, France.ORCID https://orcid.org/0000-0002-4873-0788

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Age and gender disparities within the HIV cascade of care are critical to focus interventions efficiently. We assessed gender-age groups at the highest probability of unfavorable outcomes in the HIV cascade in five HIV prevalent settings. We performed pooled data analyses from population-based surveys conducted in Kenya, South Africa, Malawi and Zimbabwe between 2012 and 2016. Individuals aged 15-59 years were eligible. Participants were tested for HIV and viral load was measured. The HIV cascade outcomes and the probability of being undiagnosed, untreated among those diagnosed, and virally unsuppressed (≥1,000 copies/mL) among those treated were assessed for several age-gender groups. Among 26,743 participants, 5,221 (19.5%) were HIV-positive (69.9% women, median age 36 years). Of them, 72.8% were previously diagnosed and 56.7% virally suppressed (88.5% among those treated). Among individuals 15-24 years, 51.5% were diagnosed vs 83.0% among 45-59 years, p<0.001. Among 15-24 years diagnosed, 60.6% were treated vs 86.5% among 45-59 years, p<0.001. Among 15-24 years treated, 77.9% were virally suppressed vs 92.0% among 45-59 years, p<0.001. Among all HIV-positive, viral suppression was 32.9% in 15-24 years, 47.9% in 25-34 years, 64.9% in 35-44 years, 70.6% in 45-59 years. Men were less diagnosed than women (65.2% vs 76.0%, p <0.001). Treatment among diagnosed and viral suppression among treated was not different by gender. Compared to women 45-59 years, young people had a higher probability of being undiagnosed (men 15-24 years OR: 37.9, women 15-24 years OR: 12.2), untreated (men 15-24 years OR:2.2, women 15-24 years OR: 5.7) and virally unsuppressed (men 15-24 years OR: 1.6, women 15-24 years OR: 6.6). In these five Eastern and Southern Africa settings, adolescents and young adults had the largest gaps in the HIV cascade. They were less diagnosed, treated, and virally suppressed, than older counterparts. Targeted preventive, testing and treating interventions should be scaled-up.

Identifiers

PMID38133999
PMCPMC10745138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.